Bevacizumab, when added to paclitaxel/carboplatin, prolongs survival in previously untreated patients with advanced non-small-cell lung cancer: Preliminary results from the ECOG 4599 trial

Preeta Tyagi, Chandra P. Belani

Research output: Contribution to journalArticle

32 Scopus citations
Original languageEnglish (US)
Pages (from-to)276-278
Number of pages3
JournalClinical Lung Cancer
Volume6
Issue number5
DOIs
StatePublished - Mar 2005

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this